Dr. Christine Seidman is the Thomas W. Smith Professor of Medicine and Genetics at Harvard Medical School, an Investigator of the Howard Hughes Medical Institute, and Director of the Cardiovascular Genetics Service at Brigham and Women’s Hospital. She was elected to the ASCI in 1992 (profile here).
Dr. Seidman has pioneered the discovery of the genetic basis for heart muscle disorders, including hypertrophic and dilated cardiomyopathies and congenital heart disease. Her work has enabled development of clinical gene-based diagnostics, early and accurate identification of at-risk individuals, and pre-emptive interventions to limit the progression and devastating outcomes associated with these disorders.
Dr. Seidman is the recipient of the American Heart Association Basic Science Prize and Joseph A. Vita Award, the ASCI Stanley J. Korsmeyer Award, the Pasarow Foundation Award in Cardiovascular Research, the Bristol-Myers Squibb Award for Distinguished Achievement in Cardiovascular Research, the Institut de France Fondation Lefoulon-Delalande Grand Prix for Science Award and the European Society of Cardiology Gold Medal. She is a member of the National Academy of Medicine and the National Academy of Science.
This event was moderated by Hossein Ardehali, MD, PhD. Dr. Ardehali, the 2021-2022 ASCI President, is Professor of Medicine-Cardiology and Professor of Pharmacology; Director, Medical Scientist Training Program; and Director, Center for Molecular Cardiology, at the Northwestern University Feinberg School of Medicine.
Tippi Cicek MacKenzie, MD
Fetal therapies for single-gene disorders
The American Society for Clinical Investigation is proud to present the ASCI Scientific Sessions: a monthly spotlight on distinguished investigator...